SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52153 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51953ALNY will release results soon of Apollo B, it's 18 month look at ATTR cardiJamesK-6/4/2022
51952I sold half my ALNY in June of last year and wish I'd chosen one of several A.J. Mullen-6/3/2022
51951Do you still own any ALNY? I have some and they are coming up on their Apollo B JamesK-6/3/2022
51950Congratulations. There must be some screaming bargains now. Big Pharma is likeA.J. Mullen16/3/2022
51949TPTX - Yay one of the ones I bought. Not a big position but I'll take it. FrJamesK-6/3/2022
51948XBI getting close to 2020 lows now. Really thought selling in this bear would moJamesK-5/9/2022
51947Paxlovid misses primary endpoint in post-exposure prophylaxis: investorshub.advDewDiligence_on_SI-4/29/2022
51946Provention Bio Announces FDA Acceptance Of The Biologics License Application ResAloner-3/21/2022
51945Thanks Frank, Much enjoyed your St. Patrick’s Day musical tribute, especially ErBulbaMan-3/17/2022
51944Happy St. Paddy’s Week! Cead Mile Failte! The Irish are on vacation until afterFrank Sully-3/14/2022
51943CLSD posts Q4 and full year results, UP 37% After Hours... ALPHARETTA, Ga., MarAloner-3/10/2022
51942CDTX only lost 2 cents today... "Biotech can be wildly under or over valuedAloner-3/4/2022
51941UC loses the CRSPR patent battle against Harvard/MIT, subject to appeal. statnewA.J. Mullen13/1/2022
51940CRISPR Technology Global Market Report 2022 Major players in the market are TheFrank Sully-2/21/2022
51939CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates Zacks EquFrank Sully12/17/2022
51938The artificial intelligence in genomics market to grow at a CAGR of 48.44% durinFrank Sully-2/10/2022
51937PRVB even more soAloner-2/10/2022
51936MDGL has certainly had a heck of an 8 day move.JamesK12/9/2022
51935CRISPR Technology Market 2022 Analysis By Size, Share, Growth, Trends up to 2026Frank Sully-2/8/2022
51934Was this an article written by AI? Too many jargons and the "promises"dna_joe-2/4/2022
51933Artificial intelligence system rapidly predicts how two proteins will attach ThFrank Sully-2/3/2022
51932The Promise of AI in Gene and Cell Therapy Operations DPS Group and Aizon discuFrank Sully-2/3/2022
51931I disagree that a larger dose necessarily increases the likelihood of problems cA.J. Mullen-2/1/2022
51930"Surely the important comparisons are effectiveness, safety, and side-effecArt Bechhoefer-2/1/2022
51929100mg, the highest dose in Madrigal's trial, doesn't seem too much to swA.J. Mullen-2/1/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News